Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi(University of Pisa), Guido Bocci(University of Pisa)
Biochemical Pharmacology
November 28, 2023
Cited by 7


Related Papers

No related papers found

Powered by citation graph analysis